Pyxis Oncology, Inc. (PYXS) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 1.65 and resistance at 1.70. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup. Pattern-based invalidation is near 1.22; losing that area would weaken the active formation considerably.

📊 Technical Summary

The latest close for Pyxis Oncology, Inc. (PYXS) came in at 1.70 (+2.41%). The stock is back above its 50-day average but still below the 200-day average, which suggests improving short-term tone within a still-repairing long-term structure. 20-day momentum is notably strong at +15.65%; price is trading in the lower part of its roughly 52-week range (1.04–5.34); and ATR14 volatility is elevated at roughly 9.21% of price. RSI(14) stands around 53.0, which keeps the momentum picture broadly balanced. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD is positioned under the signal line, suggesting momentum recovery has not fully developed yet. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The chart is currently flagging Double bottom. Near-term structure is defined by support at 1.65 and resistance at 1.70. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 2.82M · Net income: -22.00M · EPS (basic): -0.35. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more